YUHSpace

BROWSE

Export
0 157

Cited 0 times in

Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma

DC Field Value Language
dc.contributor.author정현철-
dc.date.accessioned2023-06-02T00:53:54Z-
dc.date.available2023-06-02T00:53:54Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194505-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleExploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKohei Shitara-
dc.contributor.googleauthorYung-Jue Bang-
dc.contributor.googleauthorSatoru Iwasa-
dc.contributor.googleauthorNaotoshi Sugimoto-
dc.contributor.googleauthorMin-Hee Ryu-
dc.contributor.googleauthorDaisuke Sakai-
dc.contributor.googleauthorHyun Cheol Chung-
dc.contributor.googleauthorYasushi Omuro-
dc.contributor.googleauthorHisato Kawakami-
dc.contributor.googleauthorHiroshi Yabusaki-
dc.contributor.googleauthorYasuhiro Sakamoto-
dc.contributor.googleauthorTomohiro Nishina-
dc.contributor.googleauthorKoichiro Inaki-
dc.contributor.googleauthorYusuke Kuwahara-
dc.contributor.googleauthorFumitaka Suto-
dc.contributor.googleauthorMasahiro Sugihara-
dc.contributor.googleauthorKaku Saito-
dc.contributor.googleauthorAkihito Kojima-
dc.contributor.googleauthorKensei Yamaguchi-
dc.identifier.doi10.1200/JCO.2022.40.4_suppl.322-
dc.contributor.localIdA03773-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.322-
dc.contributor.alternativeNameChung, Hyun Cheol-
dc.contributor.affiliatedAuthor정현철-
dc.citation.volume40-
dc.citation.number4 Suppl-
dc.citation.startPage322-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 Suppl) : 322, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Show simple item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links